Weiss Multi-Strategy Advisers’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-175,000	Closed	-$2.09M	–	626
2014 Q3	$2.09M	Buy	175,000 +50,000	+40%	+$341K	0.05%	295
2014 Q2	$705K	Buy	125,000 +54,620	+78%	+$252K	0.02%	465
2014 Q1	$258K	Buy	70,380 +40,380	+135%	+$154K	0.01%	861
2013 Q4	$101K	Sell	30,000 -510,000	-94%	-$2.11M	﹤0.01%	944
2013 Q3	$2.28M	Sell	540,000 -100,000	-16%	-$474K	0.05%	324
2013 Q2	$2.94M	Buy	+640,000	New	+$2.2M	0.09%	276

Other funds holding AVNR

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Weiss Multi-Strategy Advisers's AVNR Position: Q4 2014 in Review

Weiss Multi-Strategy Advisers sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q4 2014, closing a stake of 175,000 shares — an estimated $2.09M sold.

Weiss Multi-Strategy Advisers first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $2.94M in Q2 2013. 166 funds tracked by Wall St. Rank hold AVNR as of Q4 2014.

Weiss Multi-Strategy Advisers reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q4 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 175,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q4 2014, an estimated $2.09M.
Weiss Multi-Strategy Advisers first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's AVANIR PHARMACEUTICALS, INC CL A position peaked at $2.94M in Q2 2013.
166 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q4 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2014, filed 17 Feb 2015.